Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network.

Autor: Mantoan B; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy., Genuardi E; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy., Ferrante M; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy., Della Starza I; Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma, Italy.; Gimema Foundation, Rome, Italy., Ciabatti E; Division of Hematology, Department of Clinical and Experimental Medicine, Santa Chiara Hospital, Pisa, Italy., Grassi S; Division of Hematology, Department of Clinical and Experimental Medicine, Santa Chiara Hospital, Pisa, Italy., De Novi LA; Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma, Italy., Cavalli M; Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma, Italy., Mannu C; Hematopathology section, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Italy., Gazzola A; Hematopathology section, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Italy., Bomben R; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy., Degan M; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy., Alessandria B; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy., Pott C; Second Medical Department, University Hospital Schleswig-Holstein, Kiel, Germany., Delfau-Larue MH; Laboratoire d'immunologie biologique, hôpital Henri-Mondor, Créteil Cedex, France., García-Sanz R; Division of Hematology, Servicio de Hematología, Hospital Universitario de Salamanca, Spain., Agostinelli C; Hematopathology section, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, University of Bologna, Italy., Gattei V; Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico, I.R.C.C.S., Aviano, Italy., Galimberti S; Division of Hematology, Department of Clinical and Experimental Medicine, Santa Chiara Hospital, Pisa, Italy., Del Giudice I; Hematology, Department of Translational and Precision Medicine, Sapienza University of Roma, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy., Ladetto M; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.; SC Ematologia and Infrastruttura Ricerca Formazione Innovazione, Az Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Ferrero S; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy.; Hematology U, 'AOU Città della Salute e della Scienza di Torino,' Italy., Drandi D; Department of Molecular Biotechnologies and health sciences, Hematology Division, University of Torino, Italy.
Jazyk: angličtina
Zdroj: HemaSphere [Hemasphere] 2021 Sep 06; Vol. 5 (10), pp. e639. Date of Electronic Publication: 2021 Sep 06 (Print Publication: 2021).
DOI: 10.1097/HS9.0000000000000639
Databáze: MEDLINE